Objective: The aim of the study was to examine whether the neuromuscular bl
ocking potency of atracurium changes in patients with a septic intrathoraci
c process.
Design: Prospective clinical study.
Setting: Community hospital,
Participants:Thirty patients who underwent thoracic surgery for resection o
f a pulmonary carcinoma were examined. Fifteen patients showed typical sign
s of a concomitant bacterial superinfection (infection group), 15 age-match
ed patients without infection served as the control (no-infection)group.
Interventions: Relaxation was induced with atracurium, 0.6 mg/kg intravenou
sly for intubation, followed by a continuous infusion to maintain a 90% neu
romuscular blockade. Relaxometry was performed electromyographically using
the Datex Relaxograph by stimulating the ulnar nerve next to the wrist.
Measurements and Main Results: The onset time was significantly longer (5.3
+/- 2.9 v 3.3 +/- 1.2 minutes; p < 0.05), and the recovery phase (DUR 10%)
was significantly shorter (23.5 +/- 8.6 v 36.9 +/- 7.3 minutes; p < 0.001)
in the infection group compared with the controls. The infusion rate withi
n the first hour of continuous application was 77.4% higher in the infectio
n group than in the control group (11.0 +/- 2.9 v 6.2 +/- 1.0 mu g/kg/min;
p < 0.001).
Conclusion: The study showed that septic intrathoracic processes cause a cl
ear reduction of the neuromuscular blocking potency of atracurium. To guara
ntee adequate muscle relaxation in such cases, precise neuromuscular monito
ring is highly advisable. Copyright (C) 1999 by W.B. Saunders Company.